Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Edward J. Calabrese. (2008) Pharmacological Enhancement of Neuronal Survival. Critical Reviews in Toxicology 38:4, pages 349-389.
Read now
Read now
P. Florio, B. Quirici, E. Casarosa, I. Lombardi, M. Luisi, A. D. Genazzani, F. Petraglia & A. R. Genazzani. (2001) Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women. Gynecological Endocrinology 15:5, pages 359-366.
Read now
Read now
Uriel Halbreich & Linda S Kahn. (2000) Selective oestrogen receptor modulators - current and future brain and behaviour applications. Expert Opinion on Pharmacotherapy 1:7, pages 1385-1398.
Read now
Read now
Articles from other publishers (19)
Christina V. OlesonChristina V. Oleson, Tracy E. Ransom & Akinpelumi A. Beckley. 2017. Osteoporosis Rehabilitation. Osteoporosis Rehabilitation
93
110
.
Nicola Pluchino, Sara Merlini, Alessandra Cubeddu, Andrea Giannini, Fiorella Bucci, Elena Casarosa, Vito Cela, Stefano Angioni, Michele Luisi & Andrea Riccardo Genazzani. (2009) Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats. Menopause 16:5, pages 1037-1043.
Crossref
Crossref
E. Lenzi, N. Pluchino, S. Begliuomini, E. Casarosa, S. Merlini, A. Giannini, M. Luisi, N. Kumar, R. Sitruk-Ware & A.R. Genazzani. (2009) Central modifications of allopregnanolone and β-endorphin following subcutaneous administration of Nestorone. The Journal of Steroid Biochemistry and Molecular Biology 116:1-2, pages 15-20.
Crossref
Crossref
Andrea R Genazzani, Francesca Bernardi, Nicola Pluchino, Maria Silvia Giretti, Silvia Begliuomini, Elena Casarosa, Michele Luisi & Helenius J Kloosterboer. (2006) Effect of tibolone administration on central and peripheral levels of allopregnanolone and β-endorphin in female rats. Menopause 13:1, pages 57-64.
Crossref
Crossref
Liqin Zhao, Kathleen O’Neill & Roberta Diaz Brinton. (2005) Selective estrogen receptor modulators (SERMs) for the brain: Current status and remaining challenges for developing NeuroSERMs. Brain Research Reviews 49:3, pages 472-493.
Crossref
Crossref
Claudio N. Soares, Jennifer Prouty, Leslie Born & Meir Steiner. (2014) Treatment of Menopause-Related Mood Disturbances. CNS Spectrums 10:6, pages 489-497.
Crossref
Crossref
Andrea Riccardo Genazzani, Francesca Bernardi, Nicola Pluchino, Silvia Begliuomini, Elena Lenzi, Elena Casarosa & Michele Luisi. (2014) Endocrinology of Menopausal Transition and Its Brain Implications. CNS Spectrums 10:6, pages 449-457.
Crossref
Crossref
Maryvonne Le Saux & Thérèse Di Paolo. (2005) Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbens. Psychoneuroendocrinology 30:3, pages 251-260.
Crossref
Crossref
Francesca Bernardi, Elena Casarosa, Nicola Pluchino, Marco Palumbo, Alessandro David Genazzani, Stefano Luisi & Andrea Riccardo Genazzani. (2005) Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and β-endorphin. Fertility and Sterility 83:4, pages 1161-1168.
Crossref
Crossref
Andrea R Genazzani, Massimo Stomati, Francesca Bernardi, Stefano Luisi, Elena Casarosa, Simone Puccetti, Alessandro D Genazzani, Marco Palumbo & Michele Luisi. (2004) Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertility and Sterility 81, pages 757-766.
Crossref
Crossref
Kathleen O'Neill, Shuhua Chen & Roberta Diaz Brinton. (2004) Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Experimental Neurology 185:1, pages 63-80.
Crossref
Crossref
F. BERNARDI, N. PLUCHINO, M. STOMATI, M. PIERI & A. R. GENAZZANI. (2003) CNS: Sex Steroids and SERMs. Annals of the New York Academy of Sciences 997:1, pages 378-388.
Crossref
Crossref
Claudio N. Soares, Jennifer R. Poitras & Jennifer Prouty. (2003) Effect of Reproductive Hormones and Selective Estrogen Receptor Modulators on Mood during Menopause. Drugs & Aging 20:2, pages 85-100.
Crossref
Crossref
Massimo Stomati, Francesca Bernardi, Stefano Luisi, Simone Puccetti, Elena Casarosa, Martina Liut, Barbara Quirici, Matteo Pieri, Alessandro D Genazzani, Michele Luisi & Andrea R Genazzani. (2002) Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: effects on central and peripheral allopregnanolone and β-endorphin. Maturitas 43:3, pages 195-206.
Crossref
Crossref
Roberta Diaz Brinton. (2002) Selective estrogen receptor modulators (SERM) for the brain: Recent advances and remaining challenges for developing a NeuroSERM?. Drug Development Research 56:3, pages 380-392.
Crossref
Crossref
Simone J.M Neele, Reinder Evertz, Andrea R Genazzani, Michele Luisi & Coen Netelenbos. (2002) Raloxifene treatment increases plasma levels of β-endorphin in postmenopausal women: a randomized, placebo-controlled study. Fertility and Sterility 77:6, pages 1110-1117.
Crossref
Crossref
Francesca Bernardi, Massimo Stomati, Stefano Luisi, Matteo Pieri, Fernand Labrie & Andrea Riccardo Genazzani. (2002) Effects of the new generation selective estrogen receptor modulator EM-652 and oral administration of estradiol valerate on circulating, brain, and adrenal β-endorphin and allopregnanolone levels in intact fertile and ovariectomized rats. Fertility and Sterility 77:5, pages 1018-1027.
Crossref
Crossref
Valeria N. Rubin, Peter C. Ruenitz, Jason L. Boyd, F. Douglas Boudinot & Thomas E. Wiese. (2002) Characterization of selective estrogen receptor modulator (SERM) activity in two triarylethylene oxybutyric acids. Biochemical Pharmacology 63:8, pages 1517-1525.
Crossref
Crossref
Valerie L. Baker, Dale Leitman & Robert B. Jaffe. (2000) Selective Estrogen Receptor Modulators in Reproductive Medicine and Biology. Obstetrical & Gynecological Survey 55, pages S21-47.
Crossref
Crossref